Alcoholic Liver Disease: From Bench to Bedside

Author(s): Ludovico Abenavoli*.

Journal Name: Reviews on Recent Clinical Trials

Volume 14 , Issue 3 , 2019

Become EABM
Become Reviewer

[1]
Axley PD, Richardson CT, Singal AK. Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease. Clin Liver Dis 2019; 23(1): 39-50.
[2]
ICD-10 Version: 2016. Chapter V. Mental and behavioural disorders (F00-F99). Available from: http://apps.who.int/classifications/icd10/browse/ 2016/en#/F10.1.
[3]
W.H.O. Global. Status report on alcohol and health 2018. Available from: https://www.who.int/substance_abuse/publications/global_alcohol_report/en/.
[5]
O.E.C.D. Tackling Harmful Alcohol Use. Economics and Public Health Policy 2015. Available from: http://www.oecd.org/health/tackling-harmful-alcohol-use-9789264181069-en.htm.
[6]
Sheron N. Alcohol and liver disease in Europe-Simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol 2016; 64: 957-67.
[7]
European Association for the Study of the Liver EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018; 69(1): 154-81.
[8]
Masarone M, Rosato V, Dallio M, et al. Epidemiology and natural history of alcoholic liver disease. Rev Recent Clin Trials 2016; 11(3): 167-74.
[9]
Abenavoli L, Masarone M, Federico A, et al. Alcoholic hepatitis: Pathogenesis, diagnosis and treatment. Rev Recent Clin Trials 2016; 11(3): 159-66.
[10]
Boccuto L, Abenavoli L. Genetic and epigenetic profile of patients with alcoholic liver disease. Ann Hepatol 2017; 16(4): 490-500.
[11]
Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 2017; 66: 195-211.
[12]
Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and epigenetic modifiers of alcoholic liver disease. Int J Mol Sci 2018; 19(12): E3857.
[13]
Eng MY, Luczak SE, Wall TL. ALDH2, ADH1B, and ADH1C genotypes in Asians: A literature review. Alcohol Res Health 2007; 30: 22-7.
[14]
Dongiovanni P, Donati B, Fares R, et al. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013; 19: 6969-78.
[15]
Addolorato G, Mirijello A, Barrio P, Gual A. Treatment of alcohol use disorders in patients with alcoholic liver disease. J Hepatol 2016; 65(3): 618-30.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 3
Year: 2019
Page: [158 - 159]
Pages: 2
DOI: 10.2174/157488711403190718125454

Article Metrics

PDF: 26
HTML: 2